Bacariza, Jessa May .

HRN: 26-54-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2025
AMPICILLIN 1GM (VIAL)
01/27/2025
01/29/2025
IV
2 G
Q6
PROM
Waiting Final Action 
01/27/2025
CEFUROXIME 500MG (TAB)
01/27/2025
02/03/2025
ORAL
500 Mg/tab
BID
S/p NSD With RMLE
Waiting Final Action 
01/28/2025
CEFUROXIME 1.5GM (VIAL)
01/28/2025
01/29/2025
IV
1.5g
Q8h X 4 Doses
Sp NSVD With RMLE; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: